- In February 2025, Sun Pharma launched an affordable prescription-grade anti-inflammatory gel in India.
- In March 2025, Novartis received South Korean regulatory clearance for its topical JAK inhibitor.
- In January 2025, LEO Pharma developed a new anti-psoriatic cream with improved photostability in Japan.
- In April 2025, Galderma opened its Singapore R&D lab focusing on smart topical delivery systems.
